Observational studyEuropean journal of neurology2018

Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis.

C Zecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.